Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure

Keyphrases

• A1 Receptor 100%
• Adjusted Hazard Ratio 14%
• Bariatric Metabolic Surgery 100%
• Cardiovascular Outcomes 14%
• Clinical Characteristics 14%
• Confidence Interval 28%
• Congestive Heart Failure 100%
• Diabetes 14%
• Differential Effects 14%
• Glucagon-like 100%
• Glucagon-like peptide-1 Receptor (GLP-1R) 14%
• Hazard Ratio 14%
• Health Care Services 14%
• Ischemic Heart Disease 14%
• Ischemic Stroke 14%
• Living with 14%
• Maximal Weights 14%
• Obesity 14%
• Population-based Cohort 14%
• Primary Incidence 28%
• Receptor Agonist 100%
• Relative Advantage 14%
• Retrospective Cohort Study 14%
• Strong Reduction 14%
• Weight Reduction 42%

Medicine and Dentistry

• Brain Ischemia 14%
• Cardiovascular System 14%
• Congestive Heart Failure 100%
• Diabetes 14%
• Glucagon-Like Peptide-1 Agonist 100%
• Hazard Ratio 28%
• Health Service 14%
• Ischemic Heart Disease 14%
• Obesity Medicine 100%
• Retrospective Cohort Study 14%